Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Thoracic Neoplasms × Echocardiography × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Lymphoma, Non-Hodgkin 5 Lymphoma 4 Cardiotoxicity 4 Heart Failure 3 Prostatic Neoplasms 2 Heart Diseases 2 Breast Neoplasms 2 Ventricular Dysfunction, Left 1 Thoracic Neoplasms 1 Small Cell Lung Carcinoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Myelodysplastic Syndromes 1 Multiple Myeloma 1 Metastatic Solid Tumors 1 Metabolic Syndrome 1 Memory Disorders 1 Lymphoproliferative Disorders 1 Lymphomatoid Granulomatosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, B-Cell 1 Lung Neoplasms 1 Leukemia, B-Cell 1 Leukemia 1 Hodgkin Disease 1 Hereditary Breast and Ovarian Cancer Syndrome 1 Hematologic Neoplasms 1 Epstein-Barr Virus Infections 1 Diabetes Mellitus, Type 1 1

Interventions

entinostat 3 pembrolizumab 2 osimertinib 2 sotorasib 1 pralsetinib 1 ficlatuzumab 1 exemestane 1 efineptakin alfa 1 durvalumab 1 cobimetinib 1 camrelizumab 1 Tyrosine Kinase Inhibitors 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiosurgery 1 Proton Therapy 1 Pemetrexed 1 Magnetic Resonance Imaging 1 Injections, Epidural 1 Gefitinib 1 Erlotinib Hydrochloride 1 Electrocardiography 1 Echocardiography 1 Dasatinib 1 Carboplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03396614 2024-02-28

CROSS SECT

University Medical Center Groningen

Thoracic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡